Literature DB >> 33407602

Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.

Yingjie Xu1, Xiaolin Ma1, Zhixuan Zhou1, Jianguo Li2, Jun Hou1, Jia Zhu1, Min Kang1, Jianming Lai1, Xiaohui Li3.   

Abstract

BACKGROUND: To summarize the characteristics of gastrointestinal (GI) perforation in anti-nuclear matrix protein 2 (NXP2) antibody-associated juvenile dermatomyositis (JDM).
METHODS: Five patients with GI perforation from a JDM cohort of 120 cases are described. Relevant literature was reviewed.
RESULTS: Five patients, including four females and one male, were included in the study. The age of onset of these patients ranged from 3.3 to 9.5 years with the median age of 5.0 years. When these patients were complicated by GI perforation, childhood myositis assessment score (CMAS) ranged from 1 to 5 with the median score of 2. Myositis-specific antibody (MSA) spectrum analysis indicated that the five patients were anti-NXP2 antibody positive. The initial symptoms of GI perforation were progressive abdominal pain and intermittent fever. Two patients also presented with ureteral calculus with hydronephrosis and ureteral stricture. Surgery was performed in four patients. One patient failed to undergo a repair as the perforation was high in position. For the other three patients, perforation repair was successful, of which two patients failed due to recurrent perforation. At 24 months postoperative follow-up, one patient was in complete remission on prednisone (Pred) and methotrexate (MTX) treatment, and her ureteral stricture had disappeared. The other four patients died. Adding these cases with 16 other patients described in the literature, the symptom at onset was progressive abdominal pain, which often occurred within 10 months after JDM was diagnosed. Perforation most commonly occurred in the duodenum, although it also occurred at multiple sites or was recurrent. The mortality rate of GI perforation in JDM was 38% (8/21).
CONCLUSIONS: All the five perforation cases in our study subjected to MSA analysis were anti-NXP2 antibody positive. The symptom at onset was abdominal pain. The most common site of perforation was the duodenum in the retroperitoneum, and the lack of acute abdominal manifestations prevented early diagnosis. GI perforation may be a fatal complication in JDM, and early diagnosis is very important. More research is needed to determine the pathogenesis and predictive factors of GI perforation in JDM.

Entities:  

Keywords:  Anti-NXP2 antibody; Gastrointestinal perforation; Juvenile dermatomyositis

Year:  2021        PMID: 33407602     DOI: 10.1186/s12969-020-00486-x

Source DB:  PubMed          Journal:  Pediatr Rheumatol Online J        ISSN: 1546-0096            Impact factor:   3.054


  17 in total

1.  Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy.

Authors:  Gulnara Mamyrova; David E Kleiner; Laura James-Newton; Bracha Shaham; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2007-06-15

2.  Unusual cause for intestinal perforation in juvenile dermatomyositis.

Authors:  Harikrishnan Bhaskaran; Suma Balan
Journal:  BMJ Case Rep       Date:  2019-08-22

3.  The Importance of Computed Tomography for the Diagnosis Of Duodenal Perforation in a Paediatric Patient with Juvenile Dermatomyositis.

Authors:  K O Schneider; C Braeuninger; F Bergmann; B Kammer
Journal:  Klin Padiatr       Date:  2016-06-30       Impact factor: 1.349

Review 4.  Severe juvenile dermatomyositis complicated by pancreatitis.

Authors:  Y See; K Martin; M Rooney; P Woo
Journal:  Br J Rheumatol       Date:  1997-08

Review 5.  Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.

Authors:  Lauren M Pachman; Amer M Khojah
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

6.  Diagnosis and management of gastrointestinal perforations in childhood dermatomyositis with particular reference to perforations of the duodenum.

Authors:  J N Schullinger; J C Jacobs; W E Berdon
Journal:  J Pediatr Surg       Date:  1985-10       Impact factor: 2.545

7.  Mortality in children with juvenile dermatomyositis: two decades of experience from a single tertiary care centre in North India.

Authors:  Surjit Singh; Deepti Suri; Roosy Aulakh; Anju Gupta; Amit Rawat; Rohit Manoj Kumar
Journal:  Clin Rheumatol       Date:  2014-07-23       Impact factor: 2.980

8.  Required surgical therapy in the pediatric patient with dermatomyositis.

Authors:  E C Downey; M M Woolley; V Hanson
Journal:  Arch Surg       Date:  1988-09

9.  Severe Abdominal Manifestations in Juvenile Dermatomyositis.

Authors:  Caroline Besnard; Cyril Gitiaux; Muriel Girard; Louise Galmiche-Rolland; Cécile Talbotec; Pierre Quartier; Christine Bodemer; Laureline Berteloot; Brigitte Bader-Meunier
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-02       Impact factor: 2.839

10.  [Digestive manifestations of juvenile dermatomyositis. A case report and review of the literature].

Authors:  E Ghayad; A Tohme; H Ingea
Journal:  J Med Liban       Date:  1993
View more
  2 in total

1.  Gastrointestinal Involvement in Dermatomyositis.

Authors:  Ana Matas-Garcia; José C Milisenda; Gerard Espinosa; Míriam Cuatrecasas; Albert Selva-O'Callaghan; Josep María Grau; Sergio Prieto-González
Journal:  Diagnostics (Basel)       Date:  2022-05-11

2.  An Unusual Cause of Necrotising Fasciitis in a Young Male with Juvenile Dermatomyositis.

Authors:  Adelaide Ankomaa Asante; Josephine Nsaful; Dzifa Dey
Journal:  Case Rep Rheumatol       Date:  2022-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.